Trial Details
COMPLETEDBasic Information
| Clinical ID | c1522 |
|---|---|
| Identifier | NCT00545389 |
| Trial Title | Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Participant Information
| Sponsor | Shire |
|---|---|
| City | Bonheiden |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2003-02-10 |
|---|---|
| Primary Completion Date | 2004-10-20 |
| Completion Date | 2004-10-20 |